SWK Holdings Corporation (SWKH) Income Statement Analysis

See more : Iochpe-Maxion S.A. (MYPK3.SA) Income Statement Analysis – Financial Results

Complete financial analysis of SWK Holdings Corporation (SWKH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SWK Holdings Corporation, a leading company in the Asset Management industry within the Financial Services sector.

You may be interested

SWK Holdings Corporation (SWKH)

Industry: Asset Management

Sector: Financial Services

Website: https://www.swkhold.com

About SWK Holdings Corporation

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998
Revenue	37.76M	41.48M	56.16M	36.71M	30.75M	25.99M	37.49M	22.38M	23.46M	17.40M	6.45M	637.00K	0.00	0.00	45.26M	65.22M	60.79M	54.03M	43.13M	48.90M	61.01M	79.09M	86.87M	119.25M	14.10M	2.00M
Cost of Revenue	3.44M	6.95M	7.35M	4.27M	1.18M	0.00	0.00	0.00	10.00K	0.00	0.00	0.00	0.00	0.00	16.54M	20.69M	17.24M	12.90M	11.74M	11.94M	12.83M	32.65M	50.61M	50.05M	5.40M	400.00K
Gross Profit	34.32M	34.53M	48.81M	32.44M	29.57M	25.99M	37.49M	22.38M	23.45M	17.40M	6.45M	637.00K	0.00	0.00	28.72M	44.53M	43.55M	41.13M	31.39M	36.96M	48.18M	46.44M	36.26M	69.20M	8.70M	1.60M
Gross Profit Ratio	90.90%	83.24%	86.92%	88.37%	96.18%	100.00%	100.00%	100.00%	99.96%	100.00%	100.00%	100.00%	0.00%	0.00%	63.45%	68.28%	71.64%	76.13%	72.78%	75.59%	78.97%	58.72%	41.74%	58.03%	61.70%	80.00%
Research & Development	0.00	6.95M	7.35M	4.27M	1.18M	0.24	0.88	0.64	0.00	0.00	0.00	0.00	0.00	0.00	12.85M	13.82M	12.65M	10.77M	13.23M	19.50M	21.44M	25.93M	35.56M	42.72M	12.90M	2.30M
General & Administrative	11.23M	12.96M	13.62M	10.55M	7.43M	4.88M	4.10M	2.83M	3.38M	3.28M	1.75M	2.24M	1.55M	1.76M	8.70M	10.57M	0.00	0.00	11.38M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.19M	22.30M	0.00	0.00	17.67M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	11.23M	12.96M	13.62M	10.55M	7.43M	4.88M	4.10M	2.83M	3.38M	3.28M	1.75M	2.24M	1.55M	1.76M	17.89M	32.87M	37.16M	29.80M	29.09M	33.24M	38.26M	50.48M	90.85M	107.13M	26.20M	4.50M
Other Expenses	8.44M	-862.00K	4.06M	12.09M	7.16M	6.18M	-5.22M	1.66M	10.85M	-129.00K	-60.00K	0.00	0.00	0.00	5.06M	500.00K	288.00K	133.00K	6.46M	2.41M	7.32M	76.42M	746.99M	896.75M	82.00M	1.50M
Operating Expenses	19.67M	19.05M	17.68M	22.64M	14.59M	11.06M	4.10M	4.49M	14.23M	3.28M	1.75M	2.24M	1.55M	1.76M	35.79M	47.19M	50.10M	40.70M	48.78M	55.15M	67.02M	152.83M	873.39M	1.05B	121.10M	8.30M
Cost & Expenses	19.35M	26.01M	25.03M	26.91M	15.77M	11.06M	4.10M	4.49M	14.23M	3.28M	1.75M	2.24M	1.55M	1.76M	52.33M	67.88M	67.34M	53.60M	60.52M	67.08M	79.85M	185.48M	924.00M	1.10B	126.50M	8.70M
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.84M	17.53M	10.00K	49.00K	158.00K	254.00K	275.00K	7.00K	27.00K	87.00K	172.00K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	1.85M	340.00K	374.00K	455.00K	338.00K	160.00K	0.00	0.00	381.00K	589.00K	68.00K	158.00K	254.00K	275.00K	978.00K	369.00K	858.00K	207.00K	88.00K	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	2.91M	26.12M	22.92M	28.08M	14.10M	11.61M	5.22M	3.90M	10.00K	3.00K	2.00K	5.00K	2.00K	275.00K	1.69M	1.78M	1.30M	1.59M	2.46M	6.82M	15.41M	30.55M	153.61M	896.75M	82.00M	1.50M
EBITDA	19.04M	12.43M	37.45M	21.90M	19.93M	13.89M	42.77M	17.89M	-326.00K	7.95M	4.44M	-1.60M	-1.55M	-177.00K	1.69M	-1.51M	-5.25M	1.59M	-17.86M	-12.59M	-9.30M	-75.84M	-683.52M	-2.17B	-30.60M	-11.00M
EBITDA Ratio	50.42%	44.13%	62.66%	59.65%	64.83%	53.46%	114.09%	79.95%	39.40%	81.25%	71.88%	-250.86%	0.00%	0.00%	-11.88%	-1.31%	-7.75%	8.55%	-19.07%	-14.37%	-2.32%	-33.94%	25.20%	1,687.94%	-170.92%	-270.00%
Operating Income	14.65M	15.48M	31.13M	9.81M	14.98M	14.93M	33.39M	17.89M	2.60M	14.13M	4.70M	-1.60M	-1.55M	-1.76M	-8.42M	-3.24M	-7.12M	-271.00K	-17.86M	-21.58M	-20.55M	-101.31M	-939.62M	-977.40M	-112.40M	-6.70M
Operating Income Ratio	38.80%	37.31%	55.43%	26.71%	48.71%	57.44%	89.06%	79.95%	11.07%	81.18%	72.90%	-251.65%	0.00%	0.00%	-18.60%	-4.97%	-11.70%	-0.50%	-41.41%	-44.13%	-33.68%	-128.09%	-1,081.64%	-819.64%	-797.16%	-335.00%
Total Other Income/Expenses	-37.00K	-477.00K	1.88M	-22.05M	-3.93M	-673.00K	-9.38M	-7.49M	-3.69M	-824.00K	-209.00K	158.00K	453.00K	1.03M	43.31M	-411.00K	-739.00K	-1.94M	88.00K	128.00K	-314.00K	913.00K	-705.42M	-2.09B	-6.30M	6.40M
Income Before Tax	14.61M	9.49M	33.01M	3.67M	16.84M	6.24M	24.00M	10.40M	-1.09M	13.30M	4.49M	-1.45M	-1.09M	-727.00K	34.90M	-3.65M	-7.85M	-2.21M	-17.77M	-21.45M	-20.86M	-150.31M	-1.65B	-3.07B	-118.70M	-6.50M
Income Before Tax Ratio	38.70%	22.88%	58.79%	9.98%	54.78%	24.00%	64.03%	46.48%	-4.65%	76.44%	69.66%	-226.84%	0.00%	0.00%	77.10%	-5.60%	-12.92%	-4.08%	-41.20%	-43.87%	-34.19%	-190.04%	-1,893.68%	-2,575.22%	-841.84%	-325.00%
Income Tax Expense	-1.27M	-4.00M	7.08M	-1.54M	-6.99M	42.00K	15.75M	-21.64M	3.27M	-10.30M	-9.84M	-24.00K	-26.00K	-20.00K	3.00K	5.00K	167.00K	219.00K	196.00K	314.00K	318.00K	-10.28M	105.76M	2.09B	6.40M	-400.00K
Net Income	15.89M	13.49M	25.93M	5.20M	23.83M	6.20M	3.05M	28.89M	-7.37M	20.77M	12.86M	-1.42M	-1.07M	-707.00K	34.89M	-3.66M	-8.02M	-2.43M	-17.97M	-21.77M	-20.97M	-96.11M	-942.90M	-3.07B	-118.80M	-6.30M
Net Income Ratio	42.07%	32.52%	46.17%	14.17%	77.50%	23.84%	8.13%	129.08%	-31.42%	119.34%	199.50%	-223.08%	0.00%	0.00%	77.10%	-5.60%	-13.19%	-4.49%	-41.66%	-44.52%	-34.37%	-121.52%	-1,085.41%	-2,575.22%	-842.55%	-315.00%
EPS	1.26	1.05	2.03	0.40	1.85	0.47	0.23	2.22	-0.57	3.20	3.10	-0.34	-0.26	-0.17	8.50	-0.89	-2.16	-0.70	-5.83	-7.52	-8.72	-42.90	-686.09	-3.96K	-773.72	-100.67
EPS Diluted	1.25	1.05	2.02	0.40	1.85	0.47	0.23	2.22	-0.57	3.20	3.10	-0.34	-0.26	-0.17	8.50	-0.89	-2.16	-0.70	-5.83	-7.52	-8.72	-42.90	-686.09	-3.96K	-773.72	-100.67
Weighted Avg Shares Out	12.65M	12.84M	12.80M	12.85M	12.91M	13.05M	13.04M	13.02M	12.93M	6.49M	4.13M	4.12M	4.12M	4.12M	4.12M	4.12M	3.71M	3.46M	3.08M	2.90M	2.40M	2.24M	1.37M	776.10K	153.54K	62.58K
Weighted Avg Shares Out (Dil)	12.70M	12.88M	12.83M	12.86M	12.91M	13.05M	13.04M	13.02M	12.99M	6.49M	4.14M	4.12M	4.12M	4.12M	4.12M	4.12M	3.71M	3.46M	3.08M	2.90M	2.40M	2.24M	1.37M	776.10K	153.54K	62.58K

SWK Holdings Corporation (SWKH) Q4 2022 Earnings Call Transcript

April 3, 2023seekingalpha.com

SWK Holdings Corporation. (NASDAQ:SWKH ) Q4 2022 Earnings Conference Call April 3, 2023 10:00 AM ET Company Participants Jason Rando - Executive Vice President & Chief Operating Officer, Tiberend Strategic Advisors Jody Staggs - President & Interim Chief Executive Officer...

SWK Holdings Corporation to Report Fourth Quarter and Full-Year 2022 Financial Results

March 31, 2023prnewswire.com

Conference Call and Live Audio Webcast Scheduled for Monday, April 3, 2023, at 10:00 a.m. ET DALLAS , March 31, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to...

SWK Holdings Corporation (SWKH) Q3 2022 Earnings Call Transcript

November 11, 2022seekingalpha.com

SWK Holdings Corporation (NASDAQ:SWKH ) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Jason Rando - Executive Vice President & Chief Operating Officer, Tiberend Strategic Advisors Jody Staggs - President & Interim Chief Executive Officer...

SWK Holdings Corporation (SWKH) CEO Winston Black on Q2 2022 Results - Earnings Call Transcript

August 13, 2022seekingalpha.com

SWK Holdings Corporation (NASDAQ:SWKH ) Q2 2022 Earnings Conference Call August 11, 2022 10:00 AM ET Company Participants Jason Rando - Tiberend Strategic Advisors Winston Black - Chairman and CEO Conference Call Participants Kyle Bauser - Lake Street Capital Markets...

SWK Holdings Corporation to Report Second Quarter 2022 Financial Results

August 9, 2022prnewswire.com

Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET DALLAS , Aug. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to...

SWK Holdings Corporation to Report First Quarter 2022 Financial Results

May 10, 2022prnewswire.com

Conference Call and Live Audio Webcast Scheduled for Wednesday, May 11, 2022, at 10:00 a.m. ET DALLAS , May 10, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to...